GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Today
—
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Shukra Pharmaceuticals Ltd
Shukra Pharmaceuticals to Ratify Share Allotment Approval
BOARD ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 05 Jun 2026, 07:07 PM IST  ·  BSE ID: 976e2bcd-9c5f-4687-942a-4e15b4b0ccda
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board will meet to get shareholder approval again for a past share allotment due to a timing issue.
🤖 AI Summary
  • Board meeting scheduled June 10, 2026, to consider share allotment ratification.
  • Ratification required for member's resolution passed November 1, 2025.
  • Share allotment delay necessitates shareholder approval via postal ballot.
  • BSE provided in-principle approval January 9, 2026.
🏢 How This Affects the Company
💰
Financial Impact
The company is seeking to finalize a share allotment, which may impact its capital structure upon completion.
⚙️
Operational Impact
The company needs to initiate a postal ballot process to obtain shareholder ratification for the allotment.
⚠️
Risk Impact
Failure to ratify the allotment could delay or invalidate the capital raising, introducing financial and operational uncertainty.
👥 What This Means For Shareholders
✅
Action Required
Shareholders will be required to vote via postal ballot to ratify the share allotment approval.
👤
Who Is Affected
All shareholders of record will be affected as they will be asked to vote on the ratification of the share allotment.
🔍
Management Signal
Management is taking corrective action to address a procedural oversight in a past share allotment process.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Outcome of postal ballot on share allotment ratification.
Confirmation of completed share allotment post-ratification.
Updated capital structure post-allotment.
MEDIUM RISK Procedural delay in share allotment and requirement for retrospective shareholder approval indicate potential governance or execution issues.
💡 Investor Takeaway
Shukra Pharmaceuticals Board will meet to seek shareholder ratification for a share allotment due to a delay beyond the 15-day BSE approval window. A postal ballot will be used for approval.
❓ Frequently Asked Questions
When is Shukra Pharmaceuticals' Board meeting scheduled?
Shukra Pharmaceuticals' Board meeting is scheduled for Wednesday, June 10, 2026.
What is the primary agenda for Shukra Pharmaceuticals' Board meeting?
The primary agenda is to consider and approve the ratification of a member's resolution passed in an Extra-Ordinary General Meeting on November 1, 2025.
Why is ratification of the share allotment required?
Ratification is required because the share allotment was not completed within 15 days of receiving BSE's in-principle approval.
How will Shukra Pharmaceuticals seek shareholder approval for ratification?
The company proposes to seek shareholder approval via postal ballot under regulation 170(2) of SEBI (ICDR) Regulations.
When did Shukra Pharmaceuticals receive in-principle approval from BSE for the allotment?
Shukra Pharmaceuticals received BSE's in-principle approval on January 9, 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.